Dicerna Pharmaceuticals Inc Collaboration Agreements
7 Contracts & Agreements
- Second Amendment to Collaboration and License Agreement, by and between the Company and F. Hoffman-La Roche Inc., dated as of June 22, 2020 (Filed With SEC on August 6, 2020)
- First Amendment to Collaboration and License Agreement by and between the Company and F. Hoffman-La Roche Inc., dated as of May 22, 2020 (Filed With SEC on August 6, 2020)
- Collaboration and License Agreement by and between the Company and Alnylam Pharmaceuticals, Inc., dated as of April 3, 2020 (Filed With SEC on August 6, 2020)
- Collaboration and License Agreement, dated October 25, 2018, by and between the Company and Eli Lilly and Company (Filed With SEC on March 13, 2019)
- RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN DICERNA PHARMACEUTICALS,INC. AND KYOWA HAKKO KIRINCO., LTD. December 21, 2009 (Filed With SEC on January 29, 2014)
- RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN DICERNA PHARMACEUTICALS,INC. AND KYOWA HAKKO KIRINCO., LTD. December 21, 2009 (Filed With SEC on January 28, 2014)
- RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN DICERNA PHARMACEUTICALS,INC. AND KYOWA HAKKO KIRINCO., LTD. December 21, 2009 (Filed With SEC on January 17, 2014)
